[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100651381":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":30,"centralContacts":30,"locations":30,"responsibleParty":37,"collaborators":30,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":43,"sex":49,"minAge":30,"maxAge":30,"enrollmentInfo":50,"targetDuration":30,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":67,"whyStopped":30,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":30},{"fullName":5,"class":6},"Universidad de Granada","OTHER",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental group","EXPERIMENTAL","CIPAN = MIT + CIAT",[13],"Behavioral: CIPAN = MIT + CIAT",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group 1","ACTIVE_COMPARATOR","MIT + MIT",[19],"Behavioral: MIT + MIT",{"label":21,"type":16,"description":22,"interventionNames":23},"Control group 2","CIAT + CIAT",[24],"Behavioral: CIAT + CIAT",[26,31,34],{"type":27,"name":11,"description":28,"armGroupLabels":29,"otherNames":30},"BEHAVIORAL","The First Therapeutic Period (1st TP) takes place during the subacute phase, from 10 to 15 weeks since the patient's stroke onset. The Second Therapeutic Period (2nd TP) occurs during the chronic phase, from 27 to 32 weeks since the patient's stroke onset. MIT sessions (1st TP) will last one hours each and will be administered daily (5 days per week) over six weeks, amounting to a total of 30 hours of therapy. CIAT sessions (2nd TP) will be three-hour long and delivered on a daily basis (also 5 days per week) for two weeks, resulting in a total of 30 hours of therapy.",[9],null,{"type":27,"name":17,"description":32,"armGroupLabels":33,"otherNames":30},"The First Therapeutic Period (1st TP) takes place during the subacute phase, from 10 to 15 weeks since the patient's stroke onset. The Second Therapeutic Period (2nd TP) occurs during the chronic phase, from 27 to 32 weeks since the patient's stroke onset. MIT sessions (1st TP) will last one hours each and will be administered daily (5 days per week) over six weeks, amounting to a total of 30 hours of therapy. MIT sessions (2nd TP) will last one hours each and will be administered daily (5 days per week) over six weeks, amounting to a total of 30 hours of therapy.",[15],{"type":27,"name":22,"description":35,"armGroupLabels":36,"otherNames":30},"The First Therapeutic Period (1st TP) takes place during the subacute phase, from 10 to 15 weeks since the patient's stroke onset. The Second Therapeutic Period (2nd TP) occurs during the chronic phase, from 27 to 32 weeks since the patient's stroke onset. CIAT sessions (1st TP) will be three-hour long and delivered on a daily basis (also 5 days per week) for two weeks, resulting in a total of 30 hours of therapy. CIAT sessions (2nd TP) will be three-hour long and delivered on a daily basis (also 5 days per week) for two weeks, resulting in a total of 30 hours of therapy.",[21],{"type":38,"investigatorFullName":39,"investigatorTitle":40,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"PRINCIPAL_INVESTIGATOR","Antonio Bernal Benítez","Associate professor","100651381","combined-intervention-program-for-non-fluent-aphasia-based-on-neuroplasticity-100651381",false,"NCT07759375","Combined Intervention Program for Non-fluent Aphasia Based on Neuroplasticity","Combining Melodic Intonation Therapy and Constraint-Induced Aphasia Therapy for the Treatment of Non-fluent Aphasia: A Neuroplasticity-based Sequential Protocol for a Randomized Controlled Trial","CIPAN","Inclusion Criteria:\n\n* Have suffered a single LH stroke, with the RH remaining entirely intact;\n* Have a diagnosis of non-fluent aphasia characterized by non-fluent speech-with or without agrammatism, paraphasias, or stereotypies-anomia, and relatively preserved auditory comprehension;\n* Be within 9 weeks post-stroke at the time of enrollment;\n* Have no hearing, neurological, or psychiatric impairments;\n* Not be taking any medication that could affect language processing\n\nExclusion Criteria:\n\n\\-","ALL",{"count":51,"type":52},48,"ESTIMATED","INTERVENTIONAL",[55],"NA","Sequentially applying Melodic Intonation Therapy (MIT) during the subacute phase, followed by Constraint-Induced Aphasia Therapy (CIAT) during the chronic phase",[58],"Non-fluent Aphasia",[60,61,62,63,64,65,66],"Non-fluent aphasia","Neuroplasticity","Melodic Intonation Therapy","Constraint-Induced Aphasia Therapy","Subacute phase","Chronic phase","Stroke","NOT_YET_RECRUITING","2026-08-12",{"date":70,"type":71},"2026-08-14","ACTUAL",{"date":73,"type":52},"2027-01",{"date":75,"type":52},"2029-07",{"name":5,"class":6}]